Major Shareholding Notification • Nov 13, 2025
Major Shareholding Notification
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 4604H
Cicor Technologies Ltd
13 November 2025
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
| (a) Full name of discloser: | Cicor Technologies Ltd. |
| (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. |
N/A |
| (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree |
Cicor Technologies Ltd. |
| (d) Is the discloser the offeror or the offeree? | Offeror |
| (e) Date position held: The latest practicable date prior to the disclosure |
12 November 2025 |
| (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" |
No |
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
| Class of relevant security: | Ordinary (CHF 10.00) | |||
| Interests | Short positions | |||
| Number | % | Number | % | |
| (1) Relevant securities owned and/or controlled: | Nil | - | Nil | - |
| (2) Cash-settled derivatives: | Nil | - | Nil | - |
| (3) Stock-settled derivatives (including options) and agreements to purchase/sell: | Nil | - | Nil | - |
| TOTAL: | Nil | - | Nil | - |
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
| Class of relevant security in relation to which subscription right exists: | N/A |
| Details, including nature of the rights concerned and relevant percentages: | N/A |
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:
A) Interests in ordinary shares in Cicor Technologies Ltd. held by directors and executive leadership team of Cicor Technologies Ltd. and their close relatives and related trusts
| Name | Number of Cicor Technologies Ltd. ordinary shares | Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%)[1] |
| Daniel Frutig[2] | 9,101 | 0.21 |
| Norma Corio[3] | 1,278 | 0.03 |
| Denise Koopmans[4] | 1,685 | 0.04 |
| Alexander Hagemann | 18,534 | 0.42 |
| Peter Neumann | 5,231 | 0.12 |
| Marco Kechele | 2,303 | 0.05 |
| Total | 38,132 | 0.87 |
B) Interests held as options or awards (whether vested or unvested and whether or not subject to conditions) held by directors and executive leadership team of Cicor Technologies Ltd. in ordinary shares in Cicor Technologies Ltd.
| Name | Scheme under which granted | Date of grant | Price at grant (exercise price) (CHF) | Number of ordinary shares | Vesting date | Expiry date |
| Daniel Frutig | N/A[5] | 17 April 2025 | Nil | 1,093 | 16 April 2026 | N/A |
| Norma Corio | N/A[6] | 17 April 2025 | Nil | 875 | 16 April 2026 | N/A |
| Denise Koopmans | N/A[7] | 17 April 2025 | Nil | 875 | 16 April 2026 | N/A |
| Alexander Hagemann | PSOP 2022-2024 | 1 January 2022 | 52.80 | 4,032 | 31 December 2024[8] | 31 December 2028 |
| PSOP 2023-2025 | 1 January 2023 | 42.90 | 6,743 | 31 December 2025[9] | 31 December 2029 | |
| PSOP 2024-2026 | 1 January 2024 | 49.80 | 22,430 | 31 December 2026 | 31 December 2030 | |
| PSOP 2025-2027 | 1 January 2025 | 60.00 | 23,726 | 31 December 2027 | 31 December 2031 | |
| PSP 2023-2025 | 1 January 2023 | Nil | 4,578 | 31 December 2025[10] | N/A | |
| PSP 2024-2026 | 1 January 2024 | Nil | 10,892 | 31 December 2026 | N/A | |
| PSP 2025-2027 | 1 January 2025 | Nil | 9,340 | 31 December 2027 | N/A | |
| Special PSP | 1 September 2025 | Nil | 2,324 | 31 December 2027 | N/A | |
| Peter Neumann | PSOP 2023-2025 | 1 January 2023 | 42.90 | 3,372 | 31 December 2025[11] | 31 December 2029 |
| PSOP 2024-2026 | 1 January 2024 | 49.80 | 11,691 | 31 December 2026 | 31 December 2030 | |
| PSOP 2025-2027 | 1 January 2025 | 60.00 | 12,513 | 31 December 2027 | 31 December 2031 | |
| PSP 2023-2025 | 1 January 2023 | Nil | 2,288 | 31 December 2025 | N/A | |
| PSP 2024-2026 | 1 January 2024 | Nil | 5,676 | 31 December 2026 | N/A | |
| PSP 2025-2027 | 1 January 2025 | Nil | 4,926 | 31 December 2027 | N/A | |
| Special PSP | 1 September 2025 | Nil | 2,008 | 31 December 2027 | N/A | |
| Marco Kechele | PSOP 2023-2025 | 1 January 2023 | 42.90 | 3,372 | 31 December 2025[12] | 31 December 2029 |
| PSOP 2024-2026 | 1 January 2024 | 49.80 | 10,059 | 31 December 2026 | 31 December 2030 | |
| PSOP 2025-2027 | 1 January 2025 | 60.00 | 10,826 | 31 December 2027 | 31 December 2031 | |
| PSP 2023-2025 | 1 January 2023 | Nil | 2,288 | 31 December 2025 | N/A | |
| PSP 2024-2026 | 1 January 2024 | Nil | 4,884 | 31 December 2026 | N/A | |
| PSP 2025-2027 | 1 January 2025 | Nil | 4,262 | 31 December 2027 | N/A | |
| Special PSP | 1 September 2025 | Nil | 2,008 | 31 December 2027 | N/A |
C) Interests in ordinary shares in Cicor Technologies Ltd. held by OEP 80 B.V.
| Name | Number of Cicor Technologies Ltd. ordinary shares | Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%) |
| OEP 80 B.V. | 1,881,026 | 42.86 |
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
| Name | Agreement, arrangement or understanding | Number of Cicor Technologies Ltd. ordinary shares held by relevant person(s) that the agreement, arrangement or understanding relates to[13] | Percentage of issued ordinary share capital of Cicor Technologies Ltd. |
| Daniel Frutig[14] | Contractual agreement to not dispose of shares for a three-year period ending 18 April 2026 | 1,220 | 0.03 |
| Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027 | 1,479 | 0.03 | |
| Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028 | 1,962 | 0.04 | |
| Norma Corio[15] | Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027 | 493 | 0.01 |
| Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028 | 785 | 0.02 | |
| Denise Koopmans[16] | Contractual agreement to not dispose of shares for a three-year period ending 18 April 2026 | 407 | 0.01 |
| Contractual agreement to not dispose of shares for a three-year period ending 19 April 2027 | 493 | 0.01 | |
| Contractual agreement to not dispose of shares for a three-year period ending 18 April 2028 | 785 | 0.02 | |
| Alexander Hagemann | Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028 | 1,179 | 0.03 |
| Peter Neumann | Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028 | 1,018 | 0.02 |
| Marco Kechele | Contractual agreement to not dispose of shares for a three-year period ending 1 September 2028 | 1,018 | 0.02 |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" |
| None |
(c) Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | No |
| Supplemental Form 8 (SBL) | No |
| ###### Date of disclosure: | 13 November 2025 |
| ###### Contact name: | Lukas Nänni |
| ###### Telephone number: | +41 71 913 73 09 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
[1] Excludes treasury shares. Percentages have been given to two decimal places.
[2] Shares are held through Daniel Frutig, his close relatives (Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).
[3] Shares are jointly held by Norma Corio and her close relative (Lawrence Corio).
[4] Shares are held through an associated company (K+Co Consulting GmbH).
[5] These shares were awarded as part of the overall remuneration package for the board of directors for the 2025-2026 financial year.
[6] As above.
[7] As above.
[8] The vesting date for these options based on applicable scheme rules is as stated. However, in practice, board approval of satisfaction of applicable conditions in respect of these options took place in 18 April 2025 and the stated number of options vested thereafter.
[9] For options granted under the PSOP, vesting of the relevant options is subject to board approval based on the satisfaction of applicable conditions, which may take place later than 31 December of the relevant year.
[10] For shares granted under the PSP, vesting of the relevant shares is subject to board approval based on the satisfaction of applicable conditions, which may take place later than 31 December of the relevant year.
[11] As above.
[12] As above.
[13] Agreements, arrangements or understandings set out in this table relate to shares held by the relevant person(s) as disclosed under section 3(A) above.
[14] Shares are held through Daniel Frutig, his close relatives (Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).
[15] Shares are jointly held by Norma Corio and her close relative (Lawrence Corio).
[16] Shares are held through an associated company (K+Co Consulting GmbH).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FEEBJBBTMTABBPA
Have a question? We'll get back to you promptly.